Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17123902> ?p ?o }
Showing triples 1 to 20 of
20
with 100 triples per page.
- Q17123902 subject Q8431759.
- Q17123902 subject Q8802906.
- Q17123902 abstract "Tivantinib (ARQ197; by Arqule, Inc.) is an experimental anti-cancer drug. It is a bisindolylmaleimide that binds to the dephosphorylated MET kinase in vitro. Tivantinib is being tested clinically as a highly selective MET inhibitor. However, the mechanism of action of tivantinib is still unclear.Tivantinib displays cytotoxic activity via molecular mechanisms that are independent from its ability to bind MET.Possible applications include non-small-cell lung carcinoma, hepatocellular carcinoma, and oesophageal cancer.".
- Q17123902 thumbnail Tivantinib_structure.svg?width=300.
- Q17123902 wikiPageWikiLink Q1148337.
- Q17123902 wikiPageWikiLink Q14875866.
- Q17123902 wikiPageWikiLink Q19520643.
- Q17123902 wikiPageWikiLink Q221681.
- Q17123902 wikiPageWikiLink Q3658562.
- Q17123902 wikiPageWikiLink Q372701.
- Q17123902 wikiPageWikiLink Q8431759.
- Q17123902 wikiPageWikiLink Q8802906.
- Q17123902 type ChemicalSubstance.
- Q17123902 type Drug.
- Q17123902 type ChemicalObject.
- Q17123902 type Thing.
- Q17123902 type Q8386.
- Q17123902 comment "Tivantinib (ARQ197; by Arqule, Inc.) is an experimental anti-cancer drug. It is a bisindolylmaleimide that binds to the dephosphorylated MET kinase in vitro. Tivantinib is being tested clinically as a highly selective MET inhibitor.".
- Q17123902 label "Tivantinib".
- Q17123902 depiction Tivantinib_structure.svg.